Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial-Reference-Cited by-同舟云学术

Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial

Published:2022-04-02 Issue:1 Volume:19 Page:285-295
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Fruijtier Agnetha D.¹²^ORCID,van der Schaar Jetske¹,van Maurik Ingrid S.¹³,Zwan Marissa D.¹,Scheltens Philip¹,Bouwman Femke¹,Pijnenburg Yolande A.L.¹,van Berckel Bart N.M.⁴,Ebenau Jarith¹,van der Flier Wiesje M.¹³,Smets Ellen M.A.²,Visser Leonie N.C.¹⁵

Affiliation:

1. Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands

2. Department of Medical Psychology Academic Medical Center Amsterdam UMC Amsterdam The Netherlands

3. Department of Epidemiology and Data Science Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands

4. Department of Radiology & Nuclear Medicine Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands

5. Center for Alzheimer Research Division of Clinical Geriatrics Department of Neurobiology Care Sciences and Society (NVS) Karolinska Institutet Solna Sweden

Funder

Alzheimer Nederland

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12630

Reference66 articles.

1. Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges

2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project

4. Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project

5. Communicating mild cognitive impairment diagnoses with and without amyloid imaging

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time;Alzheimer's & Dementia;2024-08

2. Building expert consensus regarding sharing of individual research results in Alzheimer’s disease research: a Delphi study protocol;BMJ Open;2024-08

3. “There has to be more caring”: patient and care partner experiences of the disclosure of amyloid-β PET scan results;Aging & Mental Health;2024-06-26

4. Effects of Prognostic Communication Strategies on Prognostic Perceptions, Treatment Decisions and End-Of-Life Anticipation in Advanced Cancer: An Experimental Study among Analogue Patients;Journal of Pain and Symptom Management;2024-06

5. Effects of prognostic communication strategies on emotions, coping, and appreciation of consultations: An experimental study in advanced cancer;Palliative and Supportive Care;2024-03-27